Frequently Asked Questions
The market is segmented based on Global Active Pharmaceutical Ingredient (API) Market, By Molecule (Small Molecule and Large Molecule), Type (Innovative Active Pharmaceutical Ingredients and Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, and Others), Type of Drug (Prescription Drugs and Over-the-Counter), Usage (Clinical and Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients and Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Other Therapeutic Application) – Industry Trends and Forecast to 2031.
.
The Global Active Pharmaceutical Ingredient Api Market size was valued at USD 237.81 USD Million in 2023.
The Global Active Pharmaceutical Ingredient Api Market is projected to grow at a CAGR of 6.5% during the forecast period of 2024 to 2031.
The major players operating in the market include , Novartis AG , Sanofi , Pfizer , Johnson & Johnson Private Limited , Abbott , Teva Pharmaceutical Industries , Bausch Health Companies , Sunovion Pharmaceuticals , Jazz Pharmaceuticals , AstraZeneca , GSK plc , H. Lundbeck A/S , Takeda Pharmaceutical Company Limited , Sumitomo Dainippon Pharma Co. , Cadila Pharmaceuticals among others ,.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
